California Public Employees Retirement System raised its position in Vitamin Shoppe, Inc (NYSE:VSI) by 15.7% during the first quarter, Holdings Channel reports. The firm owned 59,800 shares of the specialty retailer’s stock after buying an additional 8,100 shares during the period. California Public Employees Retirement System’s holdings in Vitamin Shoppe were worth $1,205,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Comerica Bank boosted its position in Vitamin Shoppe by 37.8% in the first quarter. Comerica Bank now owns 35,339 shares of the specialty retailer’s stock worth $689,000 after buying an additional 9,685 shares in the last quarter. Norges Bank bought a new position in Vitamin Shoppe during the fourth quarter worth $6,444,000. First Trust Advisors LP bought a new position in Vitamin Shoppe during the first quarter worth $549,000. LSV Asset Management boosted its position in Vitamin Shoppe by 109.4% in the first quarter. LSV Asset Management now owns 76,648 shares of the specialty retailer’s stock worth $1,544,000 after buying an additional 40,048 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its position in Vitamin Shoppe by 3.7% in the first quarter. Principal Financial Group Inc. now owns 181,564 shares of the specialty retailer’s stock worth $3,659,000 after buying an additional 6,408 shares in the last quarter.
Vitamin Shoppe, Inc (VSI) opened at 6.125 on Thursday. The stock has a market capitalization of $141.87 million, a PE ratio of 7.883 and a beta of 0.68. The stock’s 50 day moving average price is $10.69 and its 200 day moving average price is $16.09. Vitamin Shoppe, Inc has a 1-year low of $6.05 and a 1-year high of $28.94.
Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.39 by $0.16. The business had revenue of $304.84 million during the quarter, compared to the consensus estimate of $314.74 million. Vitamin Shoppe had a return on equity of 9.35% and a net margin of 1.43%. The business’s quarterly revenue was down 8.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.55 earnings per share. Equities research analysts forecast that Vitamin Shoppe, Inc will post $1.24 earnings per share for the current year.
VSI has been the subject of a number of analyst reports. Zacks Investment Research cut Vitamin Shoppe from a “hold” rating to a “sell” rating in a report on Wednesday, May 3rd. Morgan Stanley upgraded Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 price target for the company in a report on Thursday, May 11th. Gabelli cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Thursday, May 11th. Barclays PLC restated an “equal weight” rating and issued a $13.00 price target (down previously from $24.00) on shares of Vitamin Shoppe in a report on Sunday, May 14th. Finally, ValuEngine cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Two equities research analysts have rated the stock with a sell rating and seven have given a hold rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $21.50.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe, Inc (NYSE:VSI).
Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.